Company intelligence
NanoDx, Inc.
NanoDx, Inc. is a medical device company developing breakthrough point-of-care diagnostic solutions.
About NanoDx, Inc.
NanoDx, Inc. is a privately-held, U.S. based, medical device company developing rapid point-of-care and in-vitro diagnostic products on its proprietary nanowire biosensor platform. The NanoDx™ System provides measurement of sample analytes in minutes from a variety of sample types. It utilizes a patented nano-sensor design that includes an array of highly sensitive biosensors that can be functionalized with an array of proteins that bind with target biomarkers. The unique size and electrical properties of the nano biosensors allow detection of biomarkers and proteins in a simple, point-of-care system. FDA has not yet reviewed this product and it has not been cleared. Currently for research use only.
Verified activity
Signals from NanoDx, Inc.
2 published signals
Research & Knowledge
NanoDx, Inc. examined 51 donated brains from former rugby league players examined by the Australian Sports Brain Bank, finding 31 showed signs of chronic traumatic encephalopathy (CTE) across amateur and professional levels in players as young as their 20s.
Reported by NanoDx, Inc.
Presence & Recognition
NanoDx, Inc. notes that nearly 60 clinicians, researchers, and first responders convened at The Ohio State University in early 2026 for the first International Consensus Conference on Concussion in First Responders.
Reported by NanoDx, Inc.